https://ddn.pluspedia.org/w/index.php?action=history&feed=atom&title=Ranolazin 2026-09-06T00:29:13Z Versionsgeschichte dieser Seite in PlusPedia MediaWiki 1.43.3 https://ddn.pluspedia.org/w/index.php?title=Ranolazin&diff=42960&oldid=prev 2010-04-13T13:27:48Z

<p>Die Seite wurde neu angelegt: „<a href="/wiki/Datei:Pptpdtjpg1.png" title="Datei:Pptpdtjpg1.png">miniatur|Entstehender Artikel</a> {| class=&quot;wikitable&quot; | | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Siehe auch&#039;&#039;&#039; | align=&quot;left&quot; width=&quot;800&quot; | |- | bgcolor=&quot;#d…“</p> <p><b>Neue Seite</b></p><div>[[Datei:pptpdtjpg1.png|miniatur|Entstehender Artikel]]<br /> {| class=&quot;wikitable&quot; |<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Siehe auch&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot; |<br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Freie Übersichtsartikel&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot; |<br /> &lt;ref name=&quot;PMID16717165&quot;&gt;Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions. Circulation 113(20):2462-72 (2006) PMID 16717165 &lt;/ref&gt;&lt;ref name=&quot;PMID16267073&quot;&gt;Ranolazine is associated with cardiovascular and metabolic improvement: a win-win for patients with diabetes. Eur Heart J 27(1):5-6 (2006) PMID 16267073 &lt;/ref&gt;&lt;ref name=&quot;PMID16775092&quot;&gt;Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine. Heart 92 Suppl 4():iv6-iv14 (2006) PMID 16775092 &lt;/ref&gt;&lt;ref name=&quot;PMID16775091&quot;&gt;Late sodium current in the pathophysiology of cardiovascular disease: consequences of sodium-calcium overload. Heart 92 Suppl 4():iv1-iv5 (2006) PMID 16775091 &lt;/ref&gt;&lt;ref name=&quot;PMID16875986&quot;&gt;Ranolazine: augmenting the antianginal armamentarium. J Am Coll Cardiol 48(3):576-8 (2006) PMID 16875986 &lt;/ref&gt;<br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Wichtige Übersichtsartikel&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Medline Suchterm/ Synonyme&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#00dfdf&quot; | &#039;&#039;&#039;Was ist das&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Struktur&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Physiologie&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Knockout&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Transgen&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Mutation&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Polymorphismus&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Genexpression&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Inhibitoren&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |-<br /> | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Agonisten&#039;&#039;&#039;<br /> | align=&quot;left&quot; width=&quot;800&quot;| <br /> |}<br /> <br /> ----<br /> <br /> == Bibliographie ==<br /> &lt;references /&gt;<br /> <br /> <br /> {{LinkWP_Miniartikel|Txt=Ranolazin|Link=Ranolazin}}</div>

Ossip Groth